Amyris, Inc.
 | |
| Company type | Public |
|---|---|
| Nasdaq: AMRS Russell 2000 Index component | |
| Industry | Renewable Fuels, Anti-Malaria, Renewable Chemicals, Renewable Products |
| Founded | 2003 |
| Headquarters | Emeryville, California, USA |
Key people | John G. Melo (CEO) Eduardo Alvarez (COO) Han Kieftenbeld (CFO) Nicole Kelsey (Gen.Counsel & Secretary) |
| Brands | Biossance, Pipette and Purecane |
| Revenue |  $152.6 million (FY 2019)[1] |
Number of employees | 561 (2019)[2] |
| Website | www |
Amyris, Inc. is a synthetic biotechnology and renewable chemical company headquartered in Emeryville, California. Amyris serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets.[3]
History
Amyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 (AMRS).[4]
In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock.[5] April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.[6] The company has raised a total of $933.7M in funding by 17 investors over 21 rounds.[7]
In 2020, Amyris received Bonsucro Chain of Custody Certification, ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user.[8] During the COVID 19 pandemic, the company collaborated with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine.[9]
Awards and recognition
Biossance, the skincare brand from Amyris, was recognized as Digital Innovator of the Year at the WWD Beauty Inc Awards.[10]
References
- ^ "Amyris Annual Report - SEC filings".
- ^ "Amyris profile".
- ^ "Amyris Inc - Company Profile". Bloomberg.com.
- ^ "Amyris, Inc. Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell". www.nasdaq.com. Retrieved 2020-06-30.
- ^ Riddell, Lindsay (November 16, 2011). "Amyris buys chemicals-maker Draths". San Francisco Business Journal.
- ^ Coons, Rebecca (April 29, 2019). "Amyris raises $34 million as it pursues skin care, sweeteners, and CBD | Nuu". Biofuels Digest. Nuu Media.
- ^ "Amyris - Funding, Financials, Valuation & Investors". Crunchbase.
- ^ Staff. "Amyris' Sugarcane Is Traceable". HAPPI.
- ^ "Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine". Cision. October 22, 2020.
- ^ Writer (December 17, 2019). "WWD Beauty Inc Names Biossance Brand Digital Innovator Of The Year". markets.businessinsider.com.
